New Federal Reserve Bank of New York research reveals a widening K-shaped economy where lower-income households face rising food insecurity and financial strain, with many depleting savings to afford basic necessities. Despite low unemployment and resilient consumer spending, households experiencing food insecurity have become increasingly pessim...

Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.7...

EF Hutton has decided to maintain its Buy rating of Hoth Therapeutics (NASDAQ:HOTH) and lower its price target from $12.00 to $7.50. Shares of Hoth Therapeutics are trading down 11.41% over the last 24 hours, at $1.70 per share. A move to $7.50 would account for a 340.92% increase from the current share price. About Hoth Therapeutics Hoth Therape...

Within the last quarter, Hoth Therapeutics (NASDAQ:HOTH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 1 1 0 0 0 In the last 3 months, 5 analysts have offered 12-month price targets fo...